UnknownNCT05907824
Long-term Prognosis for Non-functional Neuroendocrine Tumors of the Pancreatic Body and Tail ≤ 3cm
Studying Neuroendocrine neoplasm of pancreas
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Fudan University
- Principal Investigator
- Xianjun Yu, MD, PhDFudan University
- Intervention
- Histopathological review, long-term prognosis and quality of life follow-up(other)
- Enrollment
- 800 enrolled
- Eligibility
- All sexes
- Timeline
- 2023 – 2023
Study locations (1)
- Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center, Shanghai, Shanghai Municipality, China
Collaborators
The Third Affiliated Hospital of Soochow University · Qilu Hospital of Shandong University · First Affiliated Hospital Xi'an Jiaotong University · Southern Medical University, China
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT05907824 on ClinicalTrials.govOther trials for Neuroendocrine neoplasm of pancreas
Additional recruiting or active studies for the same condition.